Affiliation:
1. Department of Neurology, Post Graduate Institute for Medical Education and Research (PGIMER), Chandigarh, India
2. Department of Paediatric Neurology, Post Graduate Institute for Medical Education and Research (PGIMER), Chandigarh, India
3. Department of Pharmacology, Post Graduate Institute for Medical Education and Research (PGIMER), Chandigarh, India
4. Department of Neurology,Post Graduate Institute for Medical Education and Research (PGIMER), Chandigarh, India
Abstract
:
Autism spectrum disorder (ASD) is a composite disorder of brain development with uncertain
etiology and pathophysiology. Genetic factors are important in ASD causation, although environmental
factors are also involved in ASD pathophysiology. Environmental factors might affect
the genetic processes of brain development through the modulation of molecular pathways that
might be involved with ASD. Valproic acid and propionic acid are the major environmental factors
that serve as medicine and food preservative. VPA is used as an anti-epileptic medicine, but it has
adverse effects on pregnant women and alters the developmental patterns of the embryo. It is a multi-
targeting agent and affects 5-HT, GABA, etc. PPA is a secondary metabolite of gut microbiota
that is commonly used as a food preservative. PPA plays a significant role in ASD causation by altering
the several developmental molecular pathways like PTEN/Akt, mTOR/Gskβ, Cytokines activated
pathways, etc., at the prenatal and neonatal stage. Moreover, ASD complexity might be increased
by other important factors like vitamin A deficiency. Vitamin A is important for cortical
brain development and neuronal cell differentiation. Additionally, several important genes such as
RELN, Lhx2, CREB, IL-6, NMDA, BDNF, etc., are also altered in ASD and involved in brain development,
central nervous system, and enteric nervous system. These genes affect neuronal differentiation,
hyperactivity, oxidative stress, oxytocin, and GABA imbalance lead to improper behavior
in autistic individuals. These genes are also studied in VPA and PPA ASD-like animal models.
In this review, we explored the mechanical pathways that might be altered with VPA and PPA
exposures at the embryonic developmental stage or neonatal developmental stage.
Publisher
Bentham Science Publishers Ltd.
Subject
Pharmacology,General Neuroscience
Reference87 articles.
1. Gadad BS; Hewitson L; Young KA; German DC; Neuropathology and animal models of autism: genetic and environmental factors. Autism research and treatment 2013,2013
2. Diagnostic and statistical manual of mental disorders. BMC Med 2013,17,133-137
3. Zablotsky B; Black LI; Maenner MJ; Schieve LA; Blumberg SJ; Estimated prevalence of autism and other developmental disabilities following questionnaire changes in the 2014 national health interview survey. 2014
4. Baio J.; Wiggins L.; Christensen D.L.; Maenner M.J.; Daniels J.; Warren Z.; Kurzius-Spencer M.; Zahorodny W.; Robinson Rosenberg C.; White T.; Durkin M.S.; Imm P.; Nikolaou L.; Yeargin-Allsopp M.; Lee L.C.; Harrington R.; Lopez M.; Fitzgerald R.T.; Hewitt A.; Pettygrove S.; Constantino J.N.; Vehorn A.; Shenouda J.; Hall-Lande J.; Van Naarden Braun K.; Dowling N.F.; Prevalence of autism spectrum disorder among children aged 8 years - autism and developmental disabilities monitoring network, 11 sites, united states, 2014. MMWR Surveill Summ 2018,67(6),1-23
5. Chaste P.; Leboyer M.; Autism risk factors: genes, environment, and gene-environment interactions. Dialogues Clin Neurosci 2012,14(3),281-292
Cited by
15 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献